CTSL drives the differentiation of CD4+ T cells into T-helper-17 cells, and this effect was suppressed by a small CTSL-selective inhibitor, suggesting that targeting the CTSL regulatory module could be an approach to the management of Th17 cell-driven autoimmune disorders [125]. This evidence concerns the gene CTSL and autoimmune disease.